- Oral presentation
- Open Access
The reform study: a cohort multiple randomised controlled trial
© Cockayne et al; licensee BioMed Central Ltd. 2013
- Published: 29 November 2013
- Random Sample
- Cost Effectiveness
- Daily Living
- Eligible Patient
- Patient Preference
Undertaking randomised controlled trials can be challenging. Many trials fail to recruit, there may be issues around consent, patient preferences and treatment comparisons. The patient preference and Zelen designs have attempted to address the issues around recruitment and patient preference. However the cohort multiple randomised controlled trial has been suggested as an alternative design. The REFORM study uses this design to evaluate the clinical and cost effectiveness of a multifaceted podiatry intervention consisting of an orthotic, foot and ankle exercises and footwear advice for the prevention of falls in the over 65.
Community dwelling patients over the age of 65 who have attended a podiatry clinic will be sent an REFORM invitation pack. 1,700 participants will be recruited to the REFORM cohort all of whom will complete monthly falls calendars and questionnaires which include the EQ5D, activities of daily living and fear of falling at baseline, 6 and 12 months. Data on participants who decline to be in the cohort will be collected where possible. Ethics approval has been given to invite participants who agree to be contacted again about other podiatry studies. Once the cohort is assembled the eligible patients in the cohort will be identified and a random sample of 445 participants will be offered the package of podiatry care. We will compare the outcomes of those randomly selected to receive the intervention to those who were eligible but were not randomly selected to receive the intervention i.e. those receiving usual podiatry care.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.